Guidance: Paediatric Multisystem Inflammatory Syndrome Temporally Associated with COVID-19 [open pdf - 0B]
From the Document: "Most children are asymptomatic or exhibit mild symptoms from COVID-19 [coronavirus disease 2019] infection. However, in the last two months a small number of children have been identified who develop a significant systemic inflammatory response. All children have been diagnosed and managed appropriately along standard referral pathways. Affected children may require paediatric intensive care and input from paediatric infectious diseases, cardiology, and rheumatology. This rare syndrome shares common features with other paediatric inflammatory conditions including: Kawasaki disease, staphylococcal and streptococcal toxic shock syndromes, bacterial sepsis and macrophage activation syndromes. It can also present with unusual abdominal symptoms with excessive inflammatory markers. [...] This document is to raise awareness and gives management advice to clinicians and has been developed after expert review of the cases."
Royal College of Paediatrics and Child Health
Royal College of Paediatrics and Child Health: https://www.rcpch.ac.uk/